Endothelial nitric oxide synthase regulates microvascular hyperpermeability <i>in vivo</i>
dc.contributor.author | Hatakeyama, Takuya | |
dc.contributor.author | Pappas, Peter J. | |
dc.contributor.author | Hobson, Robert W., II | |
dc.contributor.author | Boric, Mauricio P. | |
dc.contributor.author | Sessa, William C. | |
dc.contributor.author | Duran, Walter N. | |
dc.date.accessioned | 2025-01-21T01:06:04Z | |
dc.date.available | 2025-01-21T01:06:04Z | |
dc.date.issued | 2006 | |
dc.description.abstract | Nitric oxide (NO) is an important regulator of blood flow, but its role in permeability is still challenged. We tested in vivo the hypotheses that: (a) endothelial nitric oxide synthase (eNOS) is not essential for regulation of baseline permeability; (b) eNOS is essential for hyperpermeability responses in inflammation; and (c) molecular inhibition of eNOS with caveolin-1 scaffolding domain (AP-Cav) reduces eNOS-regulated hyperpermeability. We used eNOS-deficient (eNOS-/-) mice and their wild-type control as experimental animals, platelet-activating factor (PAF) at 10(-7) m as the test pro-inflammatory agent, and integrated optical intensity (IOI) as an index of microvascular permeability. PAF increased permeability in wild-type cremaster muscle from a baseline of 2.4 +/- 2.2 to a peak net value of 84.4 +/- 2.7 units, while the corresponding values in cremaster muscle of eNOS-/- mice were 1.0 +/- 0.3 and 15.6 +/- 7.7 units (P < 0.05). Similarly, PAF increased IOI in the mesentery of wild-type mice but much less in the mesentery of eNOS-/- mice. PAF increased IOI to comparable values in the mesenteries of wild-type mice and those lacking the gene for inducible NOS (iNOS). Administration of AP-Cav blocked the microvascular hyperpermeability responses to 10(-7) m PAF. We conclude that: (1) baseline permeability does not depend on eNOS; (2) eNOS and NO are integral elements of the signalling pathway for the hyperpermeability response to PAF; (3) iNOS does not affect either baseline permeability or hyperpermeability responses to PAF; and (4) caveolin-1 inhibits eNOS regulation of microvascular permeability in vivo. Our results establish eNOS as an important regulator of microvascular permeability in inflammation. | |
dc.description.funder | NHLBI NIH HHS | |
dc.fuente.origen | WOS | |
dc.identifier.doi | 10.1113/jphysiol.2006.108175 | |
dc.identifier.eissn | 1469-7793 | |
dc.identifier.issn | 0022-3751 | |
dc.identifier.uri | https://doi.org/10.1113/jphysiol.2006.108175 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/96083 | |
dc.identifier.wosid | WOS:000239011300024 | |
dc.issue.numero | 1 | |
dc.language.iso | en | |
dc.pagina.final | 281 | |
dc.pagina.inicio | 275 | |
dc.revista | Journal of physiology-london | |
dc.rights | acceso restringido | |
dc.subject.ods | 03 Good Health and Well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.title | Endothelial nitric oxide synthase regulates microvascular hyperpermeability <i>in vivo</i> | |
dc.type | artículo | |
dc.volumen | 574 | |
sipa.index | WOS | |
sipa.trazabilidad | WOS;2025-01-12 |